ThinkGenetic announces that Chief Genetic Officer, Dawn Laney, MS, CGC, CCRC, will be participating in a 19th Annual WORLDSymposium™ Satellite Symposia entitled “Understanding Phenotypic Variability in Lysosomal Diseases – Gaining a Foothold in Precision Medicine” sponsored by Takeda Pharmaceutical Company Limited.
ThinkGenetic
Finding Patients At Risk for Rare Disease
Together let’s systematically accelerate detecting at-risk individuals.
ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.